New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
08:07 EDTISIS
theflyonthewall.com: Isis Pharmaceuticals says Mipomersen continues to perform well
The company said, "Mipomersen continues to perform well and progress toward commercialization. Isis, our investigators and members of the medical community are very encouraged by the results that were presented at the AHA last week...We are disappointed with the reaction on Wall Street to what we believe is very positive news. We believe mipomersen will continue to provide results that speak for themselves." :theflyonthewall.com



News For ISIS From The Last 14 Days
Check below for free stories on ISIS the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2010
14:18 EDTISIS
theflyonthewall.com: Isis Pharmaceuticals April puts active on elevated volatility into data
Isis Pharmaceuticals is recently up 55c to $11.26. Data is expected in Q1 for Isis Pharmaceuticals mipomersen phase 3 trial study in patients with homozygous familial hypercholesterolemia. ISIS April 10 puts have traded 42 times on transaction volume of 5,060 contracts, above its open interest of 2,286 contracts. February option implied volatility is at 52, March is at 53, April is at 63, and July is at 58; above its 26-week average of 52 according to Track Data, suggesting larger price movement into data. :theflyonthewall.com
07:12 EDTISIS
theflyonthewall.com: Isis Pharmaceuticals shares could recover to mid-teens, says Citigroup

Subscribe for More Information :theflyonthewall.com